Back to GetFilings.com




SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
__________

Form 10-Q

   X    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2003

OR

_____ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission file number -0-16061

CRITICARE SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
 

Delaware
39-1501563


 
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification Number)

 
20925 Crossroads Circle, Suite 100, Waukesha, Wisconsin 53186
(Address of principal executive offices) (Zip Code)

Registrant's telephone number including area code  (262) 798-8282

                                                          N/A                                                         
Former name, former address and former fiscal year, if changed since last report.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    
Yes   X    No ___

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes ___  No   X  

Number of shares outstanding of each class of the registrant's classes of common stock as of September 30, 2003: Class A Common Stock 11,075,269 shares.

 
   

 
CRITICARE SYSTEMS, INC.
CONSOLIDATED BALANCE SHEETS
SEPTEMBER 30, 2003 AND JUNE 30, 2003

(UNAUDITED)

ASSETS
   
September 30, 2003

 

 

June 30,
 2003
 
   
 
 
CURRENT ASSETS:
     
 
     
 
 
Cash and cash equivalents
 
$
3,866,322
 
$
3,716,446
 
Accounts receivable, less allowance for doubtful accounts
    of $300,000
   
5,502,349
   
5,627,198
 
Other receivables
   
454,885
   
553,147
 
Inventories
   
6,277,910
   
6,347,208
 
Prepaid expenses
   
364,817
   
340,934
 
   
 
 
Total current assets
   
16,466,283
   
16,584,933
 
 
             
Property, plant and equipment – net
   
2,065,034
   
2,093,408
 
   
 
       
License rights and patents – net
   
82,236
   
83,986
 
 
 
 
TOTAL ASSETS
 
$
18,613,553
 
$
18,762,327
 
   
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
     
 
     
 
 
CURRENT LIABILITIES:
     
 
     
 
 
Accounts payable
 
$
2,425,979
 
$
2,272,953
 
Accrued liabilities:
   
 
       
   Compensation and commissions
   
870,381
   
850,034
 
   Product warranties
   
353,729
   
312,000
 
   Other
   
282,669
   
254,470
 
   
 
 
Total current liabilities
   
3,932,758
   
3,689,457
 
               
OTHER LONG-TERM OBLIGATIONS
   
34,654
   
38,662
 
               
TOTAL LIABILITIES
   
3,967,412
   
3,728,119
 
               
STOCKHOLDERS' EQUITY:
             
Preferred stock - $.04 par value, 500,000 shares authorized
   no shares issued or outstanding
   
---
   
---
 
Common stock - $.04 par value, 15,000,000 shares authorized, 11,204,024
   shares issued, and 11,075,269 and 11,073,832 outstanding, respectively
   
448,161
   
448,161
 
Additional paid-in capital
   
23,361,230
   
23,360,244
 
Common stock held in treasury (128,755 and 130,192 shares, respectively)
   
(416,941
)
 
(419,618
)
Subscriptions receivable
   
(225,000
)
 
(225,000
)
Retained earnings (accumulated deficit)
   
(8,517,827
)
 
(8,126,097
)
Cumulative translation adjustment
   
(3,482
)
 
(3,482
)
   
 
 
Total stockholders' equity
   
14,646,141
   
15,034,208
 
   
 
 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
 
$
18,613,553
 
$
18,762,327
 
   
 
 

See notes to consolidated financial statements.

  2  


CRITICARE SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
THREE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002
 
(UNAUDITED)

     

2003

 

 

2002 

 
     
  
   
 
 
NET SALES
 
$
6,372,417
 
$
6,304,347
 
           
COST OF GOODS SOLD
   
3,798,010
   
3,907,000
 
 
 
 
GROSS PROFIT
   
2,574,407
   
2,397,347
 
               
OPERATING EXPENSES:
             
Sales and marketing
   
1,507,446
   
1,326,960
 
Research, development and engineering
   
600,593
   
628,940
 
Administrative
   
901,258
   
957,229
 
   
 
 
Total
   
3,009,297
   
2,913,129
 
               
LOSS FROM OPERATIONS
   
(434,890
)
 
(515,782
)
 
             
OTHER INCOME (EXPENSE):
             
Interest expense
   
   
(91,533
)
Interest income
   
9,739
   
15,865
 
Other income
   
33,421
   
299,799
 
   
 
 
Total
   
43,160
   
224,131
 
             
LOSS BEFORE INCOME TAXES
   
(391,730
)
 
(291,651
)
           
INCOME TAX PROVISION
   
   
 
 
 
 
NET LOSS
 
$
(391,730
)
$
(291,651
)
   
 
 
NET LOSS PER COMMON SHARE
             
Basic and diluted
 
$
(0.04
)
$
(0.03
)
               
WEIGHTED AVERAGE NUMBER OF COMMON
   SHARES OUTSTANDING:
     
 
     
 
 
Basic and diluted
   
11,074,738
   
11,072,682
 

See notes to consolidated financial statements.

  3  


CRITICARE SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
THREE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002

(UNAUDITED)

 
 
   
2003
   
2002
 
   
 
 
OPERATING ACTIVITIES:
     
 
     
 
 
Net loss
 
$
(391,730
)
$
(291,651
)
Adjustments to reconcile net loss to net cash
  provided by (used in) operating activities:
     
 
     
 
 
    Depreciation
   
143,178
   
228,655
 
    Amortization
   
1,750
   
1,750
 
    Provision for doubtful accounts
   
2,352
   
 
    Provision for obsolete inventory
   
95,000
   
364,000
 
    Gain on sale of Immtech stock
   
   
(241,746
)
    Gain on sale of building
   
   
(41,208
)
    Changes in assets and liabilities:
             
      Accounts receivable
   
122,497
   
544,245
 
      Other receivables
   
98,262
   
(84,914
)
      Inventories
   
(43,842
)
 
(568,513
)
      Prepaid expenses
   
(23,883
)
 
(2,135
)
      Accounts payable
   
153,026
   
94,687
 
      Accrued liabilities
   
86,267
   
117,731
 
   
 
 
Net cash provided by operating activities
   
242,877
   
120,901
 
               
INVESTING ACTIVITIES:
             
Purchases of property, plant and equipment, net
   
(96,664
)
 
(306,073
)
Proceeds from sale of Immtech stock
   
   
241,746
 
Proceeds from sale of building
   
   
3,795,164
 
   
 
 
Net cash (used in) provided by investing activities
   
(96,664
)
 
3,730,837
 
               
FINANCING ACTIVITIES:
             
Retirement of long-term debt
   
   
(3,197,125
)
Repurchase of Company common stock
   
   
(121,359
)
Proceeds from issuance of common stock
   
3,663
   
9,986
 
   
 
 
Net cash provided by (used in) financing activities
   
3,663
   
(3,308,498
)
             
EFFECT OF EXCHANGE RATE CHANGES ON CASH
   
   
268
 
               
NET INCREASE IN CASH AND CASH EQUIVALENTS
   
149,876
   
543,508
 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
   
3,716,446
   
3,523,070
 
   
 
 
CASH AND CASH EQUIVALENTS, END OF PERIOD
 
$
3,866,322
 
$
4,066,578
 
   
 
 

See notes to consolidated financial statements.

  4  


CRITICARE SYSTEMS, INC.
Condensed Notes to Consolidated Financial Statements
(Unaudited)

1. Basis of Presentation

The accompanying unaudited financial statements have been prepared by Criticare Systems, Inc. (the "Company") pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and, in the opinion of the Company, include all adjustments necessary for a fair statement of results for each period shown. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such SEC rules and regulations. The Company believes that the disclosures made are adequate to prevent the financial information given from being misleading. It is suggested that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company's latest annual report and previously filed Form 10-K. Certain amounts from the fiscal 2002 finan cial statements have been reclassified to conform to the 2003 presentation.


2. Inventory Valuation

Inventory is stated at the lower of cost or market, with cost determined on the first-in, first-out method. Components of inventory consisted of the following at September 30, 2003 and June 30, 2003, respectively:

 
 
 
September 30, 2003
June 30, 2003
   
  

 
Component parts
 
$
2,981,099
 
$
2,762,803
 
Work in process
   
664,566
   
811,906
 
Finished units
   
4,127,245
   
4,172,499
 
   
 
 
Total inventories
   
7,772,910
   
7,747,208
 
Less: reserve for obsolescence
   
1,495,000
   
1,400,000
 
   
 
 
Net inventory
 
$
6,277,910
 
$
6,347,208
 


3. Investments

During fiscal 2003, the Company completely liquidated its position in its Immtech International, Inc. (“Immtech”) common stock. In the first quarter of fiscal 2003 ended September 30, 2002, the Company sold 50,000 shares and realized a gain of $241,746 that was included in other income in the accompanying consolidated statement of operations. The remaining 406,374 shares of Immtech stock after this sale were sold in the second and third quarters of fiscal 2003.

 
  5  

 
4. Property, Plant and Equipment

Property, plant and equipment consist of the following:

 
   
September 30, 2003  
   
June 30,
 2003
 
   
 
 
Machinery and equipment
  $
2,308,061
  $
2,264,697
 
Furniture and fixtures
   
919,408
   
919,077
 
Leasehold improvements
   
212,229
   
212,229
 
Demonstration and loaner monitors
   
1,253,148
   
1,346,459
 
Production tooling
   
3,670,314
   
3,617,345
 
   
 
 
Property, plant and equipment – cost
   
8,363,160
   
8,359,807
 
Less: accumulated depreciation
   
6,298,126
   
6,266,399
 
   
 
 
Property, plant and equipment - net
 
$
2,065,034
 
$
2,093,408
 

On August 30, 2002, the Company sold its building in Waukesha, Wisconsin and leased back approximately 62% of the building’s square footage. The building was sold for $4,000,000 and a gain of $41,208 was realized on the sale after the payment of commissions and fees and the funding of $105,396 in capitalized build out costs needed to split the building into two leasable spaces. The proceeds from the sale were used to retire the $3,182,160 of debt on the Company’s balance sheet at August 30, 2002 and increased the Company’s cash position by approximately $500,000.

5. Contingencies

The import and export rules applicable to all United States companies engaged in international business transactions contain compliance guidelines. Violations may result in civil or criminal penalties, or both, as well as the potential loss of export privileges.

On August 6, 2002, in part due to the new regulations imposed under the Sarbanes-Oxley Act, the Company initiated an internal review of its import and export procedures. On August 28, 2002, senior management of the Company became aware of previous events that may have violated United States import/export laws and regulations. Senior management of the Company immediately authorized an internal audit of these possible violations, focusing on the sale of medical equipment directly or indirectly into an embargoed country and possible marking issues.
 
The factual investigation pursuant to the internal audit is complete, no additional compliance issues arose, and no material marking issues were identified as a result of the investigation.

Subsequently, the Company has taken action to adopt and implement a written compliance program with respect to applicable import/export rules. The Company has also undertaken a voluntary disclosure with the relevant government agencies and has filed its completed internal audit report and all requested documents. Although there is no assurance, based upon the results of the completed internal audit and precedents, the Company believes a negotiated settlement of any violations will not have a material adverse effect on the Company. In addition, the Company does not believe that the audit result supports the denial of export privileges; however, any such penalty would have a material adverse effect on the Company's business. The Comp any further believes that the voluntary disclosure, along with other internal actions taken, will serve to mitigate any potential adverse consequences that otherwise might accrue.
 
  6  

 
6.  Guarantees

Criticare Integration, Inc., a wholly owned U.S. subsidiary of the Company, was incorporated on April 8, 2003 to supply medical equipment and supplies to medical facilities in countries in the Black Sea Economic Zone (Albania, Armenia, Azerbaijan, Bulgaria, Georgia, Romania, and the Ukraine). The Company had set up a standby letter of credit for $300,000 on behalf of a Romanian company it is working with in connection with this new venture. The standby letter of credit served as a guarantee for a $2,000,000 line of credit that had been extended by a large Austrian bank to the Romanian company to fund this project. The standby letter of credit was to expire on November 15, 2003. The line of credit was no longer deemed necessary to fund the project and was therefore cancelled prior to expiration. The related standby letter of credit from the Company guaranteeing the line of credit was also cancelled on October 2 0, 2003.

The Company also maintains a second standby letter of credit for $300,000 on behalf of the Romanian company that serves as a guarantee to fund borrowings by the Romanian company used to set up and market this project. This standby letter of credit was to expire on November 1, 2003, but was renewed through November 1, 2004 on October 16, 2003. This standby letter of credit would only be called if the cash flows from the project were not adequate to fund these costs and the Romanian company would not be able to retire the debt. The value of this remaining guarantee that was renewed was not material to the Company’s financial statements.

7. Stock Options

The Company has adopted the disclosure-only provisions of SFAS No. 123, “Accounting for Stock-Based Compensation” and SFAS No. 148, “Accounting for Stock-Based Compensation—Transition and Disclosure”. If the Company had elected to recognize compensation cost for the options granted for the three months ended September 30, 2003 and 2002, consistent with the method prescribed by SFAS No. 123, net loss and net loss per share would have been changed to the pro forma amounts indicated below: